Extract figures, tables, methods, and underlying data to audit results.
Press Enter ↵ to review
Explore by Goal
"Study hard what interests you the most in the most undisciplined, irreverent and original manner possible."
- Richard Feynman
Quick Explanation
Copied
Core value of the paper: It introduces a macrophage-focused, pathogen-activation–aware lncRNA atlas (“SMyLR”) and a workflow (“GRADR”) to infer RNA–protein interaction landscapes at scale, then mechanistically interrogates one axis (ROCKI→hnRNPs→GATA2 exon regulation) in human macrophage models
Long Explanation
Paper Review (Evidence-Based & Skeptical): A searchable atlas of pathogen-sensitive lncRNA networks in human macrophages
Received 2024-08-07; Accepted 2025-05-14 (as reported in the manuscript header).
What you can directly extract/use
Pathogen-activation–conditioned lncRNA induction programs in human macrophages and related lung contexts, including cross-cell-type comparisons and inhibitor/time-course dependencies
A scaling framework for lncRNA–protein interactor inference (“GRADR”) integrating gradient co-sedimentation with RNA-binding proteome constraints and subcellular fractionation
Mechanistic case study: ROCKI function tied to NFκB-inducible inflammatory feed-forward regulation via hnRNP-associated GATA2 mRNA processing
A consolidated searchable web registry (“SMyLR”) for lncRNA pathway dependencies, localization, and predicted interactions
Metrics below are taken directly from the manuscript’s reported aggregate percentages and overlap statements.
Figure 1 (Interaction landscape logic): GRADR as constrained RNA–protein mapping
This is a schematic built from the manuscript’s method description: Grad-seq (co-sedimentation) + OOPS-MS (RNA-binding refinement) + compartment constraints.
1) Study design & biological scope
The study focuses on human lung-relevant immune contexts and prioritizes macrophage models under pathogen-relevant stimulation. It compares alveolar epithelial cells and macrophages under bacterial stimuli and then concentrates on macrophage lncRNAs that are induced broadly across macrophage types and respond to LPS/flagellin .
Skeptical note: multiple layers of biological variability exist: primary human cell sourcing, differentiation conditions (GM-CSF vs M-CSF), and in vitro THP1 models. The manuscript addresses some aspects via cross-model comparisons and additional validations (lung slices, BAL patient correlations), but residual confounding and cell-state drift remain possible, especially for mechanistic claims .
2) Main results & mechanistic narrative
2.1 NFκB-dependent immune lncRNA programs
The manuscript reports that many LPS-induced lncRNAs are suppressed by an NFκB-pathway inhibitor and that STAT/IRF inhibition does not globally affect the induction set, with a small exception (LINC01215 showing additional TBK1–IRF3 sensitivity) .
2.2 CRISPRi multiomics reveals network-level effects
The study silences five immune-associated lncRNAs (ROCKI, AC010980, LINC00158, LINC01215, AC022816.1) with CRISPRi in THP1 macrophage-like cells and reports that these lncRNAs regulate a substantial fraction of LPS-responsive mRNA programs—reported as ~16% of LPS-responsive mRNAs and ~8% of expressed mRNAs .
2.3 GRADR + orthogonal validation
GRADR is benchmarked using known RNA/protein co-localization examples (ACTB mRNA and RMRP lncRNA) and by comparing GRADR predictions for LUCAT1 with known ChIRP-MS data, then applied to map candidates for the five immune lncRNAs .
2.4 ROCKI case study: hnRNP association and GATA2 exon regulation
Mechanistically, ROCKI silencing downregulates multiple pro-inflammatory mediators (IL1b, CCL20, IL8, PTGS2; confirmed by IL-1β ELISA), while proteome-level responses show subtler global effects. The proposed mechanism is that ROCKI binds hnRNP proteins and suppresses GATA2 mRNA by inhibiting maturation of GATA2 3’ exons 5–6, leading to reduced GATA2 abundance and altered immune mediator programs .
3) Critical appraisal (what’s strong vs what remains uncertain)
Strengths (evidence-quality focused)
Multi-omics integration: RNA-seq + CRISPRi + whole-proteome + subcellular fractionation and multiple orthogonal interaction assays (GRADR predictions followed by ChIRP-MS; CLIP validation for hnRNP L) .
Human relevance triangulation: besides cell models, it includes precision-cut lung slice stimulation and correlations of lncRNA induction with IFNB1 in BAL-derived patient cohorts .
GRADR does not, by itself, prove direct binding. The manuscript explicitly contrasts GRADR’s prediction/refinement capability with targeted purification methods and notes only partial overlap of GRADR candidates with affinity purifications for benchmark RNAs .
Case study generalization: the mechanistic depth is strongest for ROCKI; other lncRNAs in the NFκB network are assigned functional roles more broadly from CRISPRi effects and GRADR pathway enrichment .
Evolutionary conservation challenge: many lncRNAs are conserved beyond primates only weakly, limiting cross-species validation strategies and increasing the risk that “model organism” functional follow-ups miss key biology .
Attribution vs correlation in interactomes: GRADR’s co-sedimentation similarity (and downstream Pearson r thresholds) can generate indirect candidates (complex membership, co-fractionation). While orthogonal assays help, the atlas remains an inference engine and requires user-driven selection + confirmation for any specific mechanistic target .
What would most strongly disprove the paper’s central mechanism?
(i) showing that ROCKI loss does not increase GATA2 mRNA or does not alter exon 5–6 maturation in independent experimental contexts; and/or (ii) showing that manipulating the hnRNP-dependent processing steps does not reproduce the ROCKI→GATA2→inflammatory mediator axis described .
4) Data availability & reproducibility signals
The paper deposits sequencing data in GEO (GSE268546 for ChIRP-seq; GSE268547 for RNA-seq) and mass spectrometry data in PRIDE (PXD061457), with additional datasets and “Source Data” supported via Supplementary Information and the SMyLR interface .
5) Useful “next BGPT actions” (bespoke)
Optional: run an AI bioinformatics agent that can iteratively reanalyze the GEO/PRIDE-linked data (as available via the registry links) and rebuild candidate networks.
Author reviews (bespoke): open with one click
Note: if any author-name token differs from the full manuscript rendering, use the closest matching full name button.
Feedback:
Updated: April 14, 2026
BGPT Paper Review
Study Novelty
90%
The paper combines a new/packaged scaling strategy for lncRNA–protein interactome inference (GRADR) with immune-context lncRNA atlasing and a searchable registry (SMyLR), and then provides a mechanistic ROCKI-hnRNP-GATA2 exon-maturation case study tying interactome inference to functional outcome
Scientific Quality
80%
Scientific quality is strong due to multi-omics integration and orthogonal validation for the mechanistic axis, along with explicit discussion of GRADR’s limitations (prediction vs direct binding) and partial recovery relative to ChIRP-MS benchmarks .
Study Generality
70%
While the biological conclusions are macrophage- and human-immune–specific, the methodological pattern (gradient co-sedimentation + RNA-binding refinement + compartment constraints + atlas integration) should generalize to other RNA regulatory contexts; however, the low cross-species conservation of many immune lncRNAs limits broader biological portability .
Study Usefulness
80%
SMyLR is immediately useful as a searchable reference for lncRNA pathway dependencies, localization, and protein-interaction candidates, and GRADR provides a framework for hypothesis generation that is complemented with targeted validation .
Study Reproducibility
70%
Reproducibility is supported by GEO/PRIDE deposition and detailed methods, but full reproducibility of GRADR and the atlas outputs still depends on access to supplementary tables/parameters and the SMyLR/Source Data contents beyond the excerpt provided here .
Explanatory Depth
80%
The mechanistic explanation is deep for ROCKI (hnRNP binding validated; GATA2 exon maturation measured; GATA2 overexpression phenocopy), though other network members remain more at the “systems prioritization” level rather than full mechanism dissection .
Computes and visualizes, from GEO expression/protein matrices, which lncRNAs co-regulate interferon vs pro-inflammatory modules after LPS and maps them onto the reported NFκB-dependent GRADR candidate sets.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
Strongman hypothesis: “GRADR predictions are direct-binding maps.” This is unlikely because the manuscript explicitly positions GRADR as prediction and reports incomplete overlap with ChIRP-MS interactomes, implying many candidates may represent complex association rather than direct contact .
Strongman hypothesis: “One lncRNA explains most of the inflammatory effects.” The paper reports that the 5 lncRNAs collectively influence a notable fraction of the LPS-responsive transcriptome, and it shows distinct regulated gene/protein sets for different lncRNAs, arguing against single-node sufficiency ."
Quick Explanation
Long Explanation
Top Data Sources
ExportMCP
Keep Exploring
Analysis Wizard
Hypothesis Graveyard
Potential Experiments
Discussion
Explore by Goal
Ask a Follow-Up
Key Insight
